Leptin has been shown to exert neuroprotective effects in ischemia [16], Parkinson's and Alzheimer's diseases [18]–[24] and epilepsy [25], and systemic administration of leptin decreases infarct volume after focal cerebral ischemia in mice [16]. The gene discussed is LEP; the disease is early-onset autosomal dominant Alzheimer disease.